19-26
Biological and Histopathological Investigations of Moclobemide on Injured Ovarian Tissue Following Induction of Ischemia-Reperfusion in Rats
Authors: Metin Ingec , Muhammet Calik , Cemal Gundogdu , Ali Kurt , Mehmet Yilmaz , Unal Isaoglu , Suleyman Salman , Fatih Akcay , Halis Suleyman
Number of views: 454
Background: The effects of moclobemide on damaged ovarian tissue induced by ischemia-
reperfusion and damaged contralateral ovarian tissue were investigated in rats,
biochemically and histologically.
Materials and Methods: In this experimental study, 40 rats were equally divided into
four groups: 10 mg/kg moclobemide, 20 mg/kg moclobemide, ischemia/reperfusion control,
and intact control groups. A 2-2.5-cm-long vertical incision was made in the lower
abdomen of each rat in order to reach the ovaries, after which a vascular clip was placed
on the lower side of the right ovary of each animal in the two treatment groups and the
ischemia-reperfusion control group, but not in the healthy (intact control) animal group.
The purpose of this procedure was to create ischemia over the course of three hours, then
the clips were unclamped to provide reperfusion for the next two hours. At the end of
the two hours of reperfusion, all the animals were killed by high-dose anaesthesia and
their ovaries were taken and subjected to histological and biochemical (malondialdehyde,
nitric oxide, glutathione) studies.
Results: The obtained results showed that moclobemide suppressed nitric oxide and
malondialdehyde production in the ischemia - reperfusion damage area, and prevented
the decrease in endogenous antioxidant levels (glutathione) in the rat ovarian
tissue. Moclobemide also prevented infiltration of leukocytes to the ovarian tissue.
These results showed that moclobemide protected ovarian tissue against ischemiareperfusion
injury.
Conclusion: This study shows that moclobemide represses malondialdehyde and nitric
oxide production in the rat ovarian tissue subjected to ischemia-reperfusion injury and
keeps the endogenous antioxidant glutathione level from decreasing. Moclobemide also
inhibits leukocytic migration into ovarian tissue following ischemia-reperfusion injury.
From these results, it is suggested that moclobemide can be used in the treatment of ovarian
ischemia-reperfusion injury.